The FDA has extended its approval of UCB’s BIMZELX to three new indications, extending the use of the drug to a total of four ...

David Carbone, Director of the James Thoracic Oncology Center and Professor of Internal Medicine at The Ohio State University ...

The series B fundraising will support the clinical development of next-generation multivalent vaccines against respiratory ...

UCB and Biogen revealed that their Phase 3 study testing dapirolizumab pegol in people with systemic lupus erythematosus met ...

Dandelion Health used its new clinical AI marketplace to analyze real-world data, showing that GLP-1 drugs may help prevent ...

Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out in the regions that need them most. Vaccine developers are working to offer ...

Aurora Biosynthetics has launched in Australia as a subsidiary of Myeloid Therapeutics, a US-based biotech focusing on cancer immunotherapy. Myeloid uses lipid nanoparticles to deliver mRNA molecules ...

The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its nanofiber-based viral vector manufacturing technology in November. As gene therapies ...

She brings her global experience across multiple therapeutic areas to her current role leading operations at YPrime. In this position, Alison oversees project management and all teams responsible for ...